Clinical Trial Update: High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) [Phase 3]

View source ↗

Summary

Phase 3 trial update for high-risk neuroblastoma in the SIOP-Europe (SIOPEN) study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: St. Anna Kinderkrebsforschung | Conditions: Neuroblastoma | Phase 3 | Status: RECRUITING